SALES OF COMMON STOCK (Details Narrative) - USD ($)
|
|
|
12 Months Ended |
|
Dec. 18, 2024 |
May 21, 2024 |
Dec. 31, 2025 |
Dec. 31, 2024 |
May 31, 2024 |
| SaleOfCommonStockLineItems [Line Items] |
|
|
|
|
|
| Warrants and rights outstanding |
|
|
|
188,038
|
188,038
|
| Stock issuance costs incurred |
|
|
$ 195,000
|
|
|
| Proceeds from sale of stock |
|
|
4,581,282
|
|
|
| Measurement Input, Price Volatility [Member] |
|
|
|
|
|
| SaleOfCommonStockLineItems [Line Items] |
|
|
|
|
|
| Warrants and rights outstanding, measurement input |
58.51
|
58.78
|
|
|
|
| Measurement Input, Risk Free Interest Rate [Member] |
|
|
|
|
|
| SaleOfCommonStockLineItems [Line Items] |
|
|
|
|
|
| Warrants and rights outstanding, measurement input |
4.43
|
4.53
|
|
|
|
| Measurement Input, Expected Term [Member] |
|
|
|
|
|
| SaleOfCommonStockLineItems [Line Items] |
|
|
|
|
|
| Warrants and rights outstanding, term |
5 years
|
5 years
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
| SaleOfCommonStockLineItems [Line Items] |
|
|
|
|
|
| Stock issued, shares |
|
|
47,882
|
38,749
|
|
| Placement Agents [Member] |
|
|
|
|
|
| SaleOfCommonStockLineItems [Line Items] |
|
|
|
|
|
| Reimbursed offering amount |
|
$ 1,200,000
|
|
|
|
| Cash fee, percentage |
|
6.00%
|
|
|
|
| Placement Agents [Member] | Common Stock [Member] |
|
|
|
|
|
| SaleOfCommonStockLineItems [Line Items] |
|
|
|
|
|
| Reimbursed offering amount |
|
$ 80,000
|
|
|
|
| Placement Agents [Member] | Warrant [Member] |
|
|
|
|
|
| SaleOfCommonStockLineItems [Line Items] |
|
|
|
|
|
| Stock issuance costs incurred |
|
1,544,000
|
|
|
|
| Cash proceeds from issuance of stock |
|
$ 18,456,000
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
| SaleOfCommonStockLineItems [Line Items] |
|
|
|
|
|
| Stock issued, shares |
|
|
|
4,581,282
|
|
| Common Stock [Member] | Placement Agents [Member] |
|
|
|
|
|
| SaleOfCommonStockLineItems [Line Items] |
|
|
|
|
|
| Warrants and rights outstanding |
|
61,538
|
|
|
|
| Warrant [Member] | Placement Agents [Member] |
|
|
|
|
|
| SaleOfCommonStockLineItems [Line Items] |
|
|
|
|
|
| Sale of stock, description |
purchase an aggregate of 126,500 shares
of Common Stock (the “Warrant Shares”), equal to 5.0% of the number of Shares sold in the offering, at an exercise price
per share equal to $11.50, which exercise price is equal to approximately 115% of the price per share of the shares sold in the Offering.
The Underwriter’s Warrants have a term of five years, are exercisable at any time and from time to time, in whole or in part, during
the five (5) year period commencing on December 19, 2024, the closing date of the Offering, and are exercisable via “cashless exercise”
in certain circumstances.
|
purchase an
aggregate of 61,538 shares of Common Stock (the “Warrant Shares”), an amount equal to 3.0% of the number of Shares sold in
the registered direct offering. The Placement Agents’ Warrants have an exercise price per share equal to $12.19, which is equal
to approximately 125% of the price per share of the Shares sold in the Offering. Neither the Placement Agents’ Warrants nor the
Warrant Shares have been registered under the Registration Statement or otherwise. The Placement Agents’ Warrants have a term of
five years, are exercisable at any time and from time to time, in whole or in part, during the four and one-half (4 ½) year period
commencing 180 days from the closing date of the Offering, which was May 24, 2024, and are exercisable via “cashless exercise”
in certain circumstances.
|
|
|
|
| Fair value of warrants |
$ 695,000
|
$ 331,000
|
|
|
|
| Securities Purchase Agreement [Member] |
|
|
|
|
|
| SaleOfCommonStockLineItems [Line Items] |
|
|
|
|
|
| Sale of stock, per share |
|
$ 9.75
|
|
|
|
| Proceeds from sale of stock, total |
|
$ 20,000,000
|
|
|
|
| Securities Purchase Agreement [Member] | Common Stock [Member] |
|
|
|
|
|
| SaleOfCommonStockLineItems [Line Items] |
|
|
|
|
|
| Stock issued, shares |
|
2,051,282
|
|
|
|
| Underwriting Agreement [Member] |
|
|
|
|
|
| SaleOfCommonStockLineItems [Line Items] |
|
|
|
|
|
| Stock issued, shares |
2,200,000
|
|
|
|
|
| Sale of stock, per share |
$ 10.00
|
|
|
|
|
| Proceeds from sale of stock, total |
$ 25,300,000
|
|
|
|
|
| Reimbursed offering amount |
$ 1,771,000
|
|
|
|
|
| Cash fee, percentage |
7.00%
|
|
|
|
|
| Warrants and rights outstanding |
330,000
|
|
|
|
|
| Proceeds from sale of stock |
2,530,000
|
|
|
|
|
| Underwriting Agreement [Member] | Common Stock [Member] |
|
|
|
|
|
| SaleOfCommonStockLineItems [Line Items] |
|
|
|
|
|
| Reimbursed offering amount |
$ 95,000
|
|
|
|
|
| Underwriting Agreement [Member] | Warrant [Member] |
|
|
|
|
|
| SaleOfCommonStockLineItems [Line Items] |
|
|
|
|
|
| Stock issuance costs incurred |
2,092,000
|
|
|
|
|
| Cash proceeds from issuance of stock |
$ 23,208,000
|
|
|
|
|
| Underwriting Agreement [Member] | Common Stock [Member] |
|
|
|
|
|
| SaleOfCommonStockLineItems [Line Items] |
|
|
|
|
|
| Warrants and rights outstanding |
126,500
|
|
|
|
|